Addition of bone marrow aspirate to TCP show no benefit in radiographic outcomes
Ultraporous B-Tricalcium Phosphate Alone or Combined with Bone Marrow Aspirate for Benign Cavitary Lesions: Comparison in a Prospective Randomized Clinical TrialJ Bone Joint Surg Am. 2013 Jan 16;95(2):158-66. doi: 10.2106/JBJS.K.00181
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
55 patients were randomized to evaluate the healing of cavity defects filled with ultraporous B-tricalcium phosphate (TCP) versus TCP and bone marrow aspirate (TCP/BM). Patients with a benign bone lesion received either TCP or TCP/BM and were assessed at 24 months. Results revealed that while significant improvements in radiographic parameters were reported in both groups, the addition of BM did n...
Continuing Medical Education Credits
You could be earning 0.5 CME credits for each report you read.LEARN MORE